ZBH
Zimmer Biomet Holdings Inc
NYSE: ZBH · HEALTHCARE · MEDICAL DEVICES
$80.07
-3.30% today
Updated 2026-04-29
Market cap
$15.50B
P/E ratio
20.74
P/S ratio
1.84x
EPS (TTM)
$3.86
Dividend yield
1.16%
52W range
$80 – $107
Volume
2.2M
WallStSmart proprietary scores
71
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+5.3
Quality
C+6.0
Profitability
B8.0
Valuation
A3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$98.52
+23.04%
12-Month target
$85.98
+7.38%
Intrinsic (DCF)
$149.15
Margin of safety
+35.90%
2 Strong Buy6 Buy17 Hold1 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $365.90M — positive
+ 35.90% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.94B | $7.39B | $7.68B | $8.23B | $8.41B |
| Net income | $231.40M | $1.02B | $903.80M | $705.20M | $139.50M |
| EPS | — | — | — | — | $3.86 |
| Free cash flow | $1.10B | $1.19B | $1.14B | $1.47B | $365.90M |
| Profit margin | 3.33% | 13.85% | 11.77% | 8.57% | 9.05% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-01 | NOOR, JEHANZEB | Sale | 6,626 | — |
| 2026-04-01 | NOOR, JEHANZEB | Buy | 6,626 | — |
| 2026-04-01 | NOOR, JEHANZEB | Sale | 1,677 | $90.67 |
Peer comparison
Smart narrative
Zimmer Biomet Holdings Inc trades at $80.07. representing a P/E of 20.74x trailing earnings. Our Smart Value Score of 71/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $8.41B. with profit margins at 9.05%. Our DCF model estimates intrinsic value at $149.15.
Frequently asked questions
What is Zimmer Biomet Holdings Inc's stock price?
Zimmer Biomet Holdings Inc (ZBH) trades at $80.07.
Is Zimmer Biomet Holdings Inc overvalued?
Smart Value Score 71/100 (Grade B, Buy). DCF value $149.15.
What is the price target of Zimmer Biomet Holdings Inc (ZBH)?
The analyst target price is $98.52, representing +23.0% upside from the current price of $80.07.
What is the intrinsic value of Zimmer Biomet Holdings Inc (ZBH)?
Based on our DCF model, intrinsic value is $149.15, a +35.9% margin of safety versus $80.07.
What is Zimmer Biomet Holdings Inc's revenue?
TTM revenue is $8.41B.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.84x
ROE6.07%
Beta0.61
50D MA$93.01
200D MA$95.01
Shares out0.19B
Float0.19B
Short ratio—
Avg volume2.2M
Performance
1 week-12.26%
1 month-12.04%
3 months-8.04%
YTD-10.95%
1 year—
3 years—
5 years—